2O TILs and PD-L1 Early Dynamics in the Randomized Neo-CheckRay Phase II Trial Evaluating Neo-Adjuvant Immuno-Radiation and Adenosine Pathway Blockade for Early-Stage, High Risk ER+/HER2- Breast Cancer (BC)
Immuno-Oncology and Technology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要